Indian Journal of Pharmacy Practice logo
Submit
Indian Journal of Pharmacy PracticeACADEMIC PUBLISHING
Article

Acute Demyelinating Polyradiculoneuropathy in Guillain-Barré Syndrome: A Case Report Highlighting Diagnostic Challenges and Management Strategies

1, 1, 1, 1

  1. 1Department of Pharmacy Practice, Swamy Vivekanandha College of Pharmacy, Elayampalayam, Tiruchengode, Namakkal, Tamil Nadu, INDIA.

CORRESPONDENCE

Dhivyaprasath Palaniyappan

Department of Pharmacy Practice, Swamy Vivekanandha College of Pharmacy, Elayampalayam, Tiruchengode, Namakkal, Tamil Nadu, INDIA.

drdpsvcp@gmail.com

Received: 16-12-2025; Accepted: 09-03-2026.

Volume 19, Issue 3 · pp. 411-415 · 2026 · DOI: 10.5530/ijopp.20260554

ABSTRACT

A 73-year-old female with fever, muscle weakness, and back pain was diagnosed with Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP), a subtype of Guillain-Barré Syndrome (GBS). Laboratory findings showed elevated white blood cells, neutrophilia, and albuminocytological dissociation in cerebrospinal fluid. Nerve conduction studies confirmed demyelination, and imaging revealed degenerative spinal changes. She received Immunomodulatory therapy (IVIG) and supportive care, with careful management of comorbidities like hypertension and COPD. Early diagnosis and multidisciplinary care led to a positive outcome, highlighting the importance of timely intervention and monitoring to prevent complications and long-term disability.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Arumugam, P., Thomas, A. G., Singam, A. J. A. D., & Palaniyappan, D. (2026). Acute Demyelinating Polyradiculoneuropathy in Guillain-Barré Syndrome: A Case Report Highlighting Diagnostic Challenges and Management Strategies. Indian Journal of Pharmacy Practice, 19(3), 411-415. https://doi.org/10.5530/ijopp.20260554

    Copyright and licence

    © 2026 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CC BY 4.0